Literature DB >> 10818532

Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia.

J S Meyer1, G M Rauch, R A Rauch, A Haque, K Crawford.   

Abstract

Factors accelerating cerebral degenerative changes represent potentially modifiable risks for cognitive decline. Putative risks accelerating subtle cognitive decline and dementia were correlated with repeated measures of cerebral atrophy, CT densitometry, perfusions, and cognitive testing among 224 neurologically and cognitively normative aging volunteers. After age 60, cerebral atrophy, ventricular enlargement, polioaraiosis, and leukoaraiosis geometrically increased as perfusions declined. Risks accelerating perfusional decline, cerebral atrophy, polioaraiosis, and leukoaraiosis were: transient ischemic attacks (TIAs), hypertension, smoking, hyperlipidemia, male gender. At age 71.5 +/- 11.9, subtle cognitive decline began, accelerated by TIAs, hypertension, and heart disease. Leukoaraiosis began before cognitive decline. TIAs, hypertension, and hyperlipidemia correlated with vascular dementias. Excessive cortical perfusional decreases and cerebral atrophy correlated with cognitive decline. Family history of neurodegenerative disease correlated with Alzheimer's disease. We concluded that TIAs, hypertension, hyperlipidemia, smoking, and male gender accelerate cerebral degenerative changes, cognitive decline, and dementia.

Entities:  

Mesh:

Year:  2000        PMID: 10818532     DOI: 10.1111/j.1749-6632.2000.tb06393.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

1.  Cognitive impairment in persons with rheumatoid arthritis.

Authors:  So Young Shin; Patricia Katz; Margaret Wallhagen; Laura Julian
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

2.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Neurobehavioral and imaging correlates of hippocampal atrophy in a mouse model of vascular cognitive impairment.

Authors:  Kristen L Zuloaga; Wenri Zhang; Lauren A Yeiser; Blair Stewart; Ayaka Kukino; Xiao Nie; Natalie E Roese; Marjorie R Grafe; Martin M Pike; Jacob Raber; Nabil J Alkayed
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

4.  Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease.

Authors:  Uma S Yezhuvath; Jinsoo Uh; Yamei Cheng; Kristin Martin-Cook; Myron Weiner; Ramon Diaz-Arrastia; Matthias van Osch; Hanzhang Lu
Journal:  Neurobiol Aging       Date:  2010-03-31       Impact factor: 4.673

5.  Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease.

Authors:  Patrick Griffith; Peter Lichtenberg; Robert Goldman; Jennifer Payne-Parrish
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

6.  Discrepancy between subjective and objective measures of cognitive impairment in patients with rheumatoid arthritis.

Authors:  Bo Young Yoon; Joo-Hyun Lee; So Young Shin
Journal:  Rheumatol Int       Date:  2017-09-04       Impact factor: 2.631

7.  The relationship between cognitive function and physical function in rheumatoid arthritis.

Authors:  So Young Shin; Laura Julian; Patricia Katz
Journal:  J Rheumatol       Date:  2013-01-15       Impact factor: 4.666

8.  Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.

Authors:  Rachel Barker; Dannielle Wellington; Margaret M Esiri; Seth Love
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-27       Impact factor: 6.200

9.  Effect of antihypertensive therapy on cognitive functions of patients with hypertension.

Authors:  Ashok Jaiswal; V Bhavsar; N D Kantharia
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

10.  Comprehensive gene expression profiling reveals synergistic functional networks in cerebral vessels after hypertension or hypercholesterolemia.

Authors:  Wei-Yi Ong; Mary Pei-Ern Ng; Sau-Yeen Loke; Shalai Jin; Ya-Jun Wu; Kazuhiro Tanaka; Peter Tsun-Hon Wong
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.